ClinicalTrials.gg
Drug

Avelumab clinical trials

Also written Bavencio and MSB0010718C.

studies test it
161
open now
12
in phase 3
16
first study started
2013

How each study uses avelumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the avelumab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
23 Mar 2017 · BAVENCIO · BLA 761049 (FDA, Drugs@FDA)
European Union
18 Sept 2017 · Bavencio · EMEA/H/C/004338 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Avelumab
136
anti-PD-L1
5
Avelumab (MSB0010718C)
4
Anti PD-L1
4
Avelumab 10 mg/kg
2

Brand

Bavencio
48

Development codes

MSB0010718C
41
MSB00107
1

Studies by the year they started

161 studies that test it; most in 2018 (43)

Studies that test avelumab, by start year
YearStudies
20132
20142
20157
201611
201738
201843
201922
202013
20217
20228
20232
20241
20254
20261

Who runs them

Industry 34 · Other 127

Pfizer (16) · EMD Serono Research & Development Institute, Inc. (11) · National Cancer Institute (NCI) (5) · Gruppo Oncologico del Nord-Ovest (5) · M.D. Anderson Cancer Center (4) · Memorial Sloan Kettering Cancer Center (4) · Dana-Farber Cancer Institute (3) · Merck KGaA, Darmstadt, Germany (3)

Often tested with

Tested in the same studies.

Axitinib (13) · Cetuximab (8) · Palbociclib (6) · Talazoparib (5) · Gemcitabine (5) · Paclitaxel (4) · Peposertib (3) · Nivolumab (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 13, 2 in phase 3

Studies that test avelumab, phase 3 first.

Studies

Open first, then newest update. How each study uses avelumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 161

See all 161 studies that test avelumab →

Given beside what is tested · 83 — avelumab is usual care or a partner of the new treatment

Showing 20 of 83.

As the comparator · 3 — what is tested is compared with avelumab

Codes

What other systems call avelumab · ClinicalTrials.gg INT000497

  • MeSH (NLM) C000609138avelumabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) KXG2PJ551IAVELUMABConfirmed FDA, NLM, Wikidata
  • RxNorm 1875534Confirmed FDA, Wikidata
  • Wikidata Q21083261avelumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C116870AvelumabOne source FDA
  • DrugBank DB11945One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.